Winton Group’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$540K Buy
+9,200
New +$386K 0.02% 680
2025
Q3
– Sell
-18,500
Closed -$500K – 1047
2025
Q2
$500K Buy
+18,500
New +$536K 0.03% 596
2024
Q1
– Sell
-12,067
Closed -$332K – 886
2023
Q4
$332K Sell
12,067
-4,320
-26% -$104K 0.02% 508
2023
Q3
$366K Buy
+16,387
New +$421K 0.03% 471

Other funds holding VCYT

Winton Group's VCYT Position: Q2 2026 in Review

Winton Group opened a new position in Veracyte (VCYT) in Q2 2026: 9,200 shares worth $540K. The stake represents 0.02% of the portfolio and ranks #680 among its holdings. This is a return to the name: Winton Group previously reported a position in VCYT as recently as Q2 2025.

Winton Group first reported a position in VCYT in Q3 2023 and has held it in 4 quarters since. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • Winton Group held 9,200 shares of Veracyte worth $540K as of Q2 2026.
  • Veracyte was a new Winton Group position in Q2 2026.
  • Veracyte made up 0.02% of Winton Group's portfolio in Q2 2026, its #680 holding.
  • Winton Group first reported a position in Veracyte in Q3 2023 and has held it in 4 quarters since.
  • 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Winton Group's 13F filing for Q2 2026, filed 7 Aug 2026.